VERAXA Biotech AG, an emerging leader in designing novel cancer therapies, announced the initiation of cell line development for its lead BiTAC® T-cell engager (BiTAC-TCE)...
ATUM, a leading US-based provider of integrated biologics solutions, proudly announces the launch of the CHO-K1-derived discoCHO cell line for transient protein production. ATUM’s discoCHO enables...
Wheeler Bio, Inc., a contract development and manufacturing organization (CDMO), and Charles River Laboratories International, Inc. announced an agreement to implement RightSource at Wheeler...
